According to the headline, Bayer has sold a stake in its contraceptives business to Apollo as part of a €3 billion financing deal. The article body contains no substantive content, only page styling code, so no further details are available from the provided text.
This item was indexed from its published source and tied to the entity records it names. The Counterparty reports what the market says and who it says it about; it does not rewrite the original report. Read the source for the full account.